Women's Health Issues--Beyond Menopause - References

1. Rossouw JE et al. "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial." JAMA. 288, 3:321-33, 2002. www.jama.ama-assn.org

2. Kelly JP et al. "Use of postmenopausal hormone therapy since the Women's Health Initiative findings." Pharmacoepidemiol Drug Saf. April 5, 2005 [Epub ahead of print]. www3.interscience.wiley.com/cgi-bin/jhome/5669

3. North American Menopause Society. "Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society." Menopause. 11, 1:11-33, 2004. www.menopausejournal.com

4. Low Dog T. "Menopause: a review of botanical dietary supplements." Am J Med. 118, 12 Suppl 2:98-108, 2005. www-east.elsevier.com/ajm/menu.html

5. Huntley AL, Ernst E. "A systematic review of herbal medicinal products for the treatment of menopausal symptoms." Menopause. 10, 5:465-76, 2003. www.menopausejournal.com

6. Geller SE, Studee L. "Botanical and dietary supplements for menopausal symptoms: what works, what does not." J Womens Health (Larchmt). 14, 7:634-49, 2005.

7. Mahady GB. "Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms." Treat Endocrinol. 4, 3:177-84, 2005.

8. Lupu R et al. "Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth." Int J Oncol. 23, 5:1407-12, 2003. www.erlbaum.com/Journals/journals/NC/nc.htm

9. Osmers R et al. "Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms." Obstet Gynecol. 105, 5 Pt 1:1074-83, 2005. www.greenjournal.org

10. Krei-Kleiner S et al. "Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial." Maturitas. 51, 4:397-404, 2005. www.sciencedirect.com/science/journal/03785122

11. Nappi RE et al. "Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol." Gynecol Endocrinol. 20, 1:30-5, 2005.

12. Vermes G, Banhidy F, Acs N. "The effects of remifemin on subjective symptoms of menopause." Adv Ther. 22, 2:148-54, 2005.

13. Booth NL et al. "Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review." Menopause. 13, 2:251-64, 2006. www.menopausejournal.com

14. Tice JA et al. "Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial." JAMA. 290, 2:207-14, 2003. www.jama.ama-assn.org

15. van de Weijer PH, Barentsen R. "Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo." Maturitas. 42, 3:187-93, 2002. www.sciencedirect.com/science/journal/03785122

16. Hidalgo LA et al. "The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study." Gynecol Endocrinol. 21, 5:257-64, 2005.

17. Imhof M et al. "Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women." Maturitas. In press. 2006. www.sciencedirect.com/science/journal/03785122

18. Messina M, Hughes C. "Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency." J Med Food. 6, 1:1-11, 2003. www.liebertpub.com

19. Petri Nahas E et al. "Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy." Maturitas. 48, 4:372-80, 2004. www.sciencedirect.com/science/journal/03785122

20. Colacurci N et al. "Effects of soy isoflavones on menopausal neurovegetative symptoms." Minerva Ginecol. 56, 5:407-12, 2004.

21. Upmalis DH et al. "Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: A multicenter, double-blind, randomized, placebo-controlled study." Menopause. 7:236-42, 2000. www.menopausejournal.com

22. Scambia G et al. "Clinical effects of a standardized soy extract in postmenopausal women: A pilot study." Menopause. 7:105-11, 2000. www.menopausejournal.com

23. Bagchi D et al. "Benefits of resveratrol in women's health." Drugs Exp Clin Res. 27, 5-6:233-48, 2001.

24. Kupfersztain C et al. "The immediate effect of natural plant extract, Angelica sinensis and Matricaria chamomilla (Climex) for the treatment of hot flushes during menopause. A preliminary report." Clin Exp Obstet Gynecol. 30, 4:203-6, 2003.

25. Circosta C et al. "Estrogenic activity of standardized extract of Angelica sinensis." Phytother Res. Epub May 12, 2006. www.interscience.wiley.com/jpages/0951-418X

26. Lau CB et al. "Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate?" Menopause. 12, 6:734-40, 2005. www.menopausejournal.com

27. Eskeland B, Thom E, Svendsen KO. "Sexual desire in men: effects of oral ingestion of a product derived from fertilized eggs." J Int Med Res. 25, 2:62-70, 1997. www.jimronline.net

28. North American Menopause Society. "Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society." Menopause. 13, 3:340-67, 2006. www.menopausejournal.com

29. Nieves JW. "Osteoporosis: the role of micronutrients." Am J Clin Nutr. 81, 5:1232S-39S, 2005. www.ajcn.org

30. Grados F et al. "Effects of bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency." Joint Bone Spine. 70, 3:203-8, 2003.

31. Doetsch AM et al. "The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: a randomized placebo-controlled study." Calcif Tissue Int. 75, 3:183-8, 2004.

32. Jackson RD et al. "Calcium plus Vitamin D Supplementation and the Risk of Fractures." NEJM. 354, 7:669-83, 2006. http://content.nejm.org

33. Grant AM et al. "Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomized placebo-controlled trial." Lancet. 365, 9471:1621-8, 2005. www.thelancet.com

34. Porthouse J et al. "Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care." BMJ. 330, 7498:1003, 2005. http://bmj.com

35. Shea B et al. "Calcium supplementation on bone loss in postmenopausal women." Cochrane Database Syst Rev. 1:CD004526, 2004. www.cochrane.org

36. Cussler EC et al. "Exercise frequency and calcium intake predict 4-year bone changes in postmenopausal women." Osteoporos Int. 16, 12:2129-41, 2005. www.link.springer.de/link/service/journals/00198

37. Suzuki Y et al. "Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen." J Nutr Health Aging. 7, 5:296-9, 2003. www.springerpub.com

38. Rude RK, Gruber HE. "Magnesium deficiency and osteoporosis: animal and human observations." J Nutr Biochem. 15, 12:710-6, 2004. www.elsevier.com/locate/jnutbio

39. Saito N et al. "Bone mineral density, serum albumin and serum magnesium." J Am Coll Nutr. 23, 6:701S-3S, 2004. www.jacn.org

40. Ryder KM et al. "Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects." J Am Geriatr Soc. 53, 11:1875-80, 2005.

41. Rude RK et al. "Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat." Bone. 37, 2:211-9, 2005. www.elsevier.com/locate/boneonline

42. Stendig-Lindberg G et al. "Prolonged magnesium deficiency causes osteoporosis in the rat." J Am Coll Nutr. 23, 6:704S-11S, 2004. www.jacn.org

43. Fukushima Y et al. "Calcium absorption of malt drinks containing fructooligosaccharides and safety in humans." J Nutrition Food. 5, 1:49-60, 2002.

44. Tahiri M et al. "Five-week intake of short-chain fructooligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women." J Bone Min Res. 16, 11:2152-60, 2001. www.jbmr-online.org

45. Morohashi T, Ohta A, Yamada S. "Dietary fructooligosaccharides prevent a reduction of cortical and trabecular bone following total gastrectomy in rats." Jpn J Pharmacol. 82:54-8, 2000.

46. Adams J, Pepping J. "Vitamin K in the treatment and prevention of osteoporosis and arterial calcification." Am J Health Syst Pharm. 62, 15:1574-81, 2005. www.ajhp.org

47. Amizuka N, Li M, Maeda T. "[The interplay of magnesium and vitamin K2 on bone mineralization.]" Clin Calcium. 15, 7:57-61, 2005.

48. Ichikawa T et al. "Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells." J Biol Chem. 281, 25:16927-34, 2006. www.jbc.org

49. Martini LA et al. "Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism." Osteoporos Int. 17, 6:929-35, 2006. www.link.springer.de/link/service/journals/00198

50. Sato Y et al. "Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease." Bone. 36, 1:61-8, 2005. www.elsevier.com/locate/boneonline

51. Ikeda Y et al. "Intake of fermented soybeans, Natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study." J Nutr. 136:1323-8, 2006. http://jn.nutrition.org

52. Kaneki M et al. "Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: Possible implications for hip-fracture risk." Nutrition. 17:315-21, 2001. www.journals.elsevierhealth.com/periodicals/nut

53. Zhang X et al. "Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women." Arch Intern Med. 165, 16:1890-5, 2005. http://archinte.ama-assn.org

54. Roudsari AH et al. "Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial." Nutr J. 4:30, 2005. www.nutritionj.com

55. Chen YM et al. "Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight and calcium intake: a double-blind, randomized, controlled trial." Menopause. 11, 3:246-54, 2004. www.menopausejournal.com

56. Dang ZC, Lowik C. "Dose-dependent effects of phytoestrogens on bone." Trends Endocrinol Metab. 16, 5:207-13, 2005.

57. Kim MS, Lee YS. "Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats." J Med Food. 8, 4:439-45, 2005. www.liebertpub.com

58. Lee YB et al. "Evaluation of the preventive effect of soy isoflavone extract on bone loss in ovariectomized rats." Biosci Biotechnol Biochem. 68, 5:1040-5, 2004. www.jsbba.or.jp/bbindexj.html

59. Chen YM et al. "Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial." J Clin Endocrinol Metab. 88, 10:4740-7, 2003. http://jcem.endojournals.org

60. Harkness LS et al. "Decreased bone resorption with soy isoflavone supplementation in postmenopausal women." J Womens Health (Larchmt). 13, 9:1000-7, 2004.

61. Morabito N et al. "Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double blind placebo-controlled study." J Bone Min Res. 17, 10:1904-12, 2002. www.jbmr-online.org

62. Ullmann U et al. "Repeated oral once daily intake of increasing doses of the novel synthetic genistein product Bonistein in healthy volunteers." Planta Med. 71, 10:891-6, 2005.

63. Heim M et al. "The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells." Endocrinology. 145:848-59, 2004. http://endo.endojournals.org/

64. Heim M et al. "The phytoestrogen genistein activated human osteoblast survival via genomic TGF-beta signaling." Presented at International Congress for Medicinal Plant Research, Florence, Italy, August 2005.

65. Ye YB et al. "Soy isoflavones attenuate bone loss in early postmenopausal Chinese women: A single-blind, randomized, placebo-controlled trial." Eur J Nutr. Epub June 8, 2006. www.steinkopff.springer.de/journal/394/

66. Yao CH et al. "Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin, and Chinese medicine as a bone substitute." J Biomed Mater Res B Appl Biomater. 75, 2:277-88, 2005.

67. Touvier M et al. "Dietary and cancer-related behaviors of vitamin/mineral dietary supplement users in a large cohort of French women." Eur J Nutr. 45, 4:205-14, 2006. www.steinkopff.springer.de/journal/394/

68. McCullough ML et al. "Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort." Cancer Epidemiol Biomarkers Prev. 14, 12:2898-904, 2005. http://cebp.aacrjournals.org

69. Zhang SM et al. "Folate intake and risk of breast cancer characterized by hormone receptor status." Cancer Epidemiol Biomarkers Prev. 14, 8:2004-8, 2005. http://cebp.aacrjournals.org

70. Tamimi RM et al. "Plasma carotenoids, retinol, and tocopherols and risk of breast cancer." Am J Epidemiol. 161, 2:153-60, 2005. http://aje.oupjournals.org

71. Cho E et al. "Premenopausal intakes of vitamins A, C, and E, folate, and carotenoids, and risk of breast cancer." Cancer Epidemiol Biomarkers Prev. 12, 8:713-20, 2003. http://cebp.aacrjournals.org

72. Li Z et al. "[Effect of beta-carotene on gene expression of breast cancer cells.]" Ai Zheng. 22, 4:380-4, 2003.

73. Bosetti C et al. "Flavonoids and breast cancer risk in Italy." Cancer Epidemiol Biomarkers Prev. 14, 4:805-8, 2005. http://cebp.aacrjournals.org

74. Sun CL et al. "Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies." Carcinogenesis. 27, 7:1310-5, 2006. http://carcin.oupjournals.org

75. Seely D et al. "The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis." Integr Cancer Ther. 4, 2:144-55, 2005.

76. Yuan JM et al. "Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore." Carcinogenesis. 26, 8:1389-94, 2005. http://carcin.oupjournals.org

77. Thangapazham RL et al. "Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo." Cancer Lett. Epub March 3, 2006. www.elsevier.com/locate/canlet

78. Vergote D et al. "(-)-Epigallocatechin (GC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts." Breast Cancer Res Treat. 76, 3:195-201, 2002. www.springerlink.com/link.asp?id=102860

79. Bigelow RL, Cardelli JA. "The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells." Oncogene. 25, 13:1922-30, 2006.

80. Kim ND et al. "Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for breast cancer." Breast Cancer Res Treat. 71, 3:203-17, 2002. www.springerlink.com/link.asp?id=102860

81. Toi M et al. "Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo." Angiogenesis. 6, 2:121-8, 2003.

82. Mehta R, Lansky EP. "Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture." Eur J Cancer Prev. 13, 4:345-8, 2004.

83. Trock BJ, Hilakivi-Clarke L, Clarke R. "Meta-analysis of soy intake and breast cancer risk." J Natl Cancer Inst. 98, 7:459-71, 2006. http://jncicancerspectrum.oupjournals.org

84. Badger TM et al. "Soy protein isolate and protection against cancer." J Am Coll Nutr. 24, 2:146S-49S, 2005. www.jacn.org

85. Sarkar FH et al. "The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy." Mini Rev Med Chem. 6, 4:401-7, 2006.

86. Harris RM et al. "Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment." J Clin Endocrinol Metab. 89, 4:1779-87, 2004. http://jcem.endojournals.org

87. Wood CE et al. "Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast." Cancer Res. 66, 2:1241-9, 2006. http://cancerres.aacrjournals.org

88. Boyapati SM et al. "Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study." Breast Cancer Res Treat. 92, 1:11-7, 2005. www.springerlink.com/link.asp?id=102860

89. Linseisen J et al. "Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study." Int J Cancer. 110, 2:284-90, 2004. www3.interscience.wiley.com

90. Webb AL, McCullough ML. "Dietary lignans: potential role in cancer prevention." Nutr Cancer. 51, 2:117-31, 2005. www.erlbaum.com/Journals/journals/NC/nc.htm

91. McCann SE et al. "Dietary lignan intakes and risk of pre- and postmenopausal breast cancer." Int J Cancer. 111, 3:440-3, 2004. www3.interscience.wiley.com

92. Pietinen P et al. "Serum Enterolactone and Risk of Breast Cancer: A Case-Control Study in Eastern Finland." Cancer Epidemiol Biomarkers Prev. 10:339-44, 2001. http://cebp.aacrjournals.org

93. Boccardo F et al. "Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk." Breast Cancer Res Treat. 79:17-23, 2003. www.springerlink.com/link.asp?id=102860

94. Rose P et al. "Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells." Toxicol Appl Pharmacol. 209, 2:105-13, 2005.

95. Wang W et al. "Sulforaphane, erucin, and iberin up-regulate thioredoxin reductase 1 expression in human MCF-7 cells." J Agric Food Chem. 53, 5:1417-21, 2005. http://pubs.acs.org/journals/jafcau

96. Jackson SJ, Singletary KW. "Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization." J Nutr. 134, 9:2229-36, 2004. http://jn.nutrition.org

97. Tantivejkul K, Vucenik I, Shamsuddin AM. "Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells." Anticancer Res. 23, 5A:3671-9, 2003. www.geocities.com/Athens/Rhodes/8729/iiar/iiar.htm

98. Tantivejkul K, Vucenik I, Shamsuddin AM. "Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions." Anticancer Res. 23, 5A:3681-9, 2003. www.geocities.com/Athens/Rhodes/8729/iiar/iiar.htm

99. Vucenik I et al. "Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKC-delta-dependent increase in p27(Kip1) and decrease in retinoblastoma protein (pRb) phosphorylation." Breast Cancer Res Treat. 91:35-45, 2005. www.springerlink.com/link.asp?id=102860

100. Tantivejkul K et al. "Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer." Breast Cancer Res Treat. 79, 3:301-12, 2003. www.springerlink.com/link.asp?id=102860

101. Hardman WE. "(n-3) fatty acids and cancer therapy." J Nutr. 134, 12 Supp:3427S-30S, 2004. http://jn.nutrition.org

102. Bagga D et al. "Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer." Nutr Cancer. 42, 2:180-5, 2002. www.erlbaum.com/Journals/journals/NC/nc.htm

103. Schley PD et al. "Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells." Breast Cancer Res Treat. 92, 2:187-95, 2005. www.springerlink.com/link.asp?id=102860

104. Wu M et al. "Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway." Int J Cancer. 117, 3:340-8, 2005. www3.interscience.wiley.com

105. Kiani F et al. "Dietary risk factors for ovarian cancer: the Adventist Health Study (United States)." Cancer Causes Control. 17, 2:137-46, 2006.

106. Nagle CM et al. "Dietary influences on survival after ovarian cancer." Int J Cancer. 106, 2:264-9, 2003. www3.interscience.wiley.com

107. Tung KH et al. "Association with dietary vitamin A, carotenoids, and other antioxidants with the risk of ovarian cancer." Cancer Epidemiol Biomarkers Prev. 14, 3:669-76, 2005. http://cebp.aacrjournals.org

108. Larsson SC, Wolk A. "Tea consumption and ovarian cancer risk in a population-based cohort." Arch Intern Med. 165, 22:2683-6, 2005. http://archinte.ama-assn.org

109. Zhang M, Binns CW, Lee AH. "Tea consumption and ovarian cancer risk: a case-control study in China." Cancer Epidemiol Biomarkers Prev. 11, 8:713-8, 2002. http://cebp.aacrjournals.org